Developer docs
API playgroundTry for free, no card

Search company profiles

Veeva

Full company profile

uuid0003z6d

Namestring
Veeva
Legal namestring
Veeva Systems Inc.
Websiteurl
veeva.com
Company typeenum
Public
Founded yearint
2007
Descriptiontext

Veeva Systems is a public cloud software company (NYSE: VEEV) founded in 2007 and headquartered in Pleasanton, California, that builds industry-specific applications for the global life sciences sector. The company operates the Veeva Vault Platform — a validated, regulated cloud infrastructure powering five product clouds: Veeva Development Cloud (clinical, eTMF, CTMS, RTSM, EDC, CDB, eCOA), Veeva Regulatory (RIM, Submissions), Veeva Safety Suite (pharmacovigilance), Veeva Quality Cloud (QMS, Training, LIMS, Batch Release, plus new EHS module), and Veeva Commercial Cloud (Vault CRM Suite, Ostro, Campaign Manager, Events Management, PromoMats, Align, Patient CRM). Supporting layers include the Veeva Data Cloud (OpenData, Link, Compass, Crossix) and a growing AI portfolio (Vault AI, Veeva Falcon, Veeva Falcon MLR). The company serves more than 1,500 customers across pharma, biotech, MedTech, consumer health, and CDMOs, including 15 of the top 20 global biopharma companies, with 4,000+ active Vault instances and 2M+ monthly active users.

Veeva's go-to-market is direct enterprise field sales targeting life sciences organizations through multi-year subscription contracts; the company maintains 5,001-10,000 employees and operates globally across North America, Europe, Asia Pacific, Latin America, and the Middle East. Revenue is overwhelmingly recurring — approximately 89% subscription, with subscription revenue of $730.2M in Q1 FY2027 (15% YoY) and total Q1 FY2027 revenue of $882.9M (16% YoY). Full-year FY2026 revenue was $3.195B and management has guided FY2027 to $3.635-3.645B. The Vault CRM Suite shows particularly strong momentum, with 140 customers live as of May 2026 (up from 125+ earlier in the year), 27 new customers added in Q1 FY2027, and an 80%+ competitive win rate.

The company pursues an aggressive AI- and acquisition-led growth strategy. Three acquisitions were completed in 2026 — Yonalink (clinical data, February), Ostro (AI brand engagement, ~$100M, March), and Copli (agentic MLR, rebranded as Veeva Falcon MLR, June) — alongside major product launches including Veeva Falcon (agentic platform, November 2026 early access) and Veeva EHS (August 2026). Veeva was added to the S&P 500 index on May 7, 2026, and the company operates as a Public Benefit Corporation under CEO and founder Peter Gassner. Strategic data ecosystem partnerships with Snowflake (Openflow Connector) and Databricks (Genie AI agents embedded in Vault CRM) extend the platform into customer data architectures, signaling a deliberate positioning as the workflow and AI orchestration layer for life sciences.

Short descriptiontext

Veeva Systems provides cloud-based software for the global life sciences industry, serving 1,500+ customers including 15 of the top 20 biopharma companies across clinical, regulatory, safety, quality, and commercial operations on its Veeva Vault Platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPleasanton, United States
HQ citystring
Pleasanton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life sciences cloud software, clinical trial management, regulatory information management, pharmacovigilance safety systems, pharmaceutical quality management
Industry1 code
1Industry/Vertical Cloud Platforms (e.g., Gov/Healthcare/Financial Cloud Regions)
CodeHDABAAALPrimaryYes
NAICS code1 code
  • Software Publishers513210
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Life Sciences Cloud Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Subscription Revenue
TypeSubscription Recurring
Description

Veeva generates the majority of its revenue (approximately 89% of total) from subscription-based software licenses for its Vault platform applications. Customers pay annual or multi-year subscription fees based on the number of users, applications deployed, and contract value. Subscription revenue grew 15% year-over-year to $730.2 million in Q1 FY2027.

veeva.com
2Professional Services
TypeProfessional Services
Description

Implementation, consulting, and training services to help customers deploy and optimize Veeva applications. Professional services contributed $101.3 million in Q1 FY2026, representing approximately 11% of total revenue.

veeva.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise Subscription Licensing
ModelSubscriptionBilling cadenceAnnual
Notes

Annual or multi-year subscription contracts with pricing based on number of users, applications deployed, and company size. No public pricing available - requires direct sales contact.

veeva.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 18 records shown
1Veeva Vault
Description

The company's cloud-based platform for life sciences applications

veeva.com
+17 more records
Core offering1 text field

Veeva Systems provides the industry cloud for life sciences, delivering cloud-based software on the Veeva Vault Platform for pharmaceutical, biotech, and MedTech organizations. The portfolio spans Veeva Development Cloud (clinical, regulatory, safety), Veeva Quality Cloud, Veeva Medical Suite, and Veeva Commercial Cloud (CRM and engagement), supported by data products and AI capabilities including Vault AI, Veeva Falcon, and Ostro. Approximately 89% of revenue comes from subscription fees, with the remainder from professional services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • 50% faster time to market for promotional content
+9 more records
Product overview1 text field

Veeva Systems provides a comprehensive industry cloud platform for life sciences, operating as a unified platform-plus-modules architecture. The portfolio spans five core clouds: Veeva Development Cloud (encompassing Veeva Clinical Platform, eTMF, CTMS, RTSM, EDC, CDB, eCOA), Veeva Regulatory (RIM, Registrations, Submissions), Veeva Safety Suite (Safety, SafetyDocs, Safety Signal, Safety Workbench), Veeva Quality Cloud (QualityDocs, QMS, Training, LIMS, Validation Management, Batch Release), and Veeva Commercial Cloud (Vault CRM Suite, Ostro, Campaign Manager, Events Management, Align, Patient CRM, PromoMats, Nitro). Supporting these are data products (OpenData, Veeva Link, Veeva Compass) and AI capabilities (Vault AI, Veeva Falcon, Veeva Falcon MLR). The platform serves pharma, biotech, MedTech, and other life sciences organizations across clinical, regulatory, quality, medical, and commercial operations.

Product and service36 records
1Veeva Vault Platform
2Veeva Development Cloud
3Veeva Clinical Platform
4Veeva eTMF
5Veeva CTMS
6Veeva RTSM
7Veeva EDC
8Veeva CDB
9Veeva eCOA
10Veeva RIM
11Veeva Submissions
12Veeva Safety Suite
13Veeva Safety
14Veeva Safety Signal
15Veeva Quality Cloud
16Veeva QualityDocs
17Veeva QMS
18Veeva Training
19Veeva LIMS
20Veeva Medical Suite
21Veeva Vault CRM Suite
22Ostro
CategoryCommercial
Description

AI-powered brand engagement platform providing instant compliant answers for patients and HCPs using conversational AI and semantic search drawn from MLR-approved materials; trusted by 50% of the Top 20 global pharmaceutical companies.

23Veeva Campaign Manager
CategoryCommercial
Description

Marketing automation application for coordinating sales and marketing engagement in unified campaigns using both non-personal and field channels with segmented, multi-action campaigns.

24Veeva Events Management
25Veeva Align
26Veeva Patient CRM
27Veeva PromoMats
28Veeva Nitro
29Veeva OpenData
30Veeva Link
31Veeva Compass
32Vault AI
33Veeva Falcon
CategoryAI
Description

Agentic platform with standard agents for life sciences drug development processes including trial master file document intake, health authority correspondence, and safety case triage; Veeva's first offering in 'agentic labor' for the industry.

34Veeva Falcon MLR
CategoryAI
Description

Agentic Medical, Legal, and Regulatory content-review platform that automates promotional and medical material reviews against approved labels and local regulations, aiming to eliminate over 70% of manual MLR work within five years.

35Veeva EHS
CategoryQuality
Description

Environmental, Health, and Safety management application within Veeva Quality Cloud for proactive risk identification and mitigation while ensuring compliance with global requirements.

36SiteVault
Scale indicator23 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2026-06-23
Description

Veeva acquired Copli, a Copenhagen-based pioneer in agentic medical, legal, and regulatory (MLR) solutions for the life sciences industry. Copli was rebranded as Veeva Falcon MLR, an agentic automation solution that automates promotional and medical material reviews against approved labels and local regulations.

Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-06-01
Description

ELIQUENT Life Sciences announced the June 1 go-live of Veeva Safety Suite at UCB, marking one of the first deployments of the complete suite globally. The transformation unified UCB's pharmacovigilance operations across case processing, signal management, and reporting into a single cloud-based platform. ELIQUENT led the implementation as the strategic collaboration partner.

Strategic tierMajorTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-06-01
Description

Daelight Solutions was part of the strategic collaboration delivering Veeva Safety Suite at UCB, migrating 14 million documents and 80 million records into the single cloud-based platform.

Strategic tierMajorTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-06-01
Description

Pinnaxis was part of the strategic collaboration delivering Veeva Safety Suite at UCB, providing implementation services for the pharmacovigilance transformation.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-18
Description

Databricks and Veeva integrated their platforms to enable life sciences commercial teams to access real-time AI-powered insights directly within Veeva Vault CRM workflows. The integration embeds Databricks Genie AI agents and AI/BI dashboards into the CRM, allowing field teams to query patient signals, HCP prioritization data, KOL information, and territory analytics on demand.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-07
Description

Accumulus Technologies announced live integration with Veeva RIM, creating real-time connection between Veeva's regulatory information management system and the Accumulus platform for global health authority collaboration. The integration enables life sciences companies to manage regulatory interactions directly within their existing Veeva RIM environment, eliminating manual reconciliation and system switching. Amgen is among the first companies to deploy the solution.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-06
Description

Snowflake and Veeva announced a collaboration to connect Snowflake's AI Data Cloud for Healthcare & Life Sciences with the Veeva Vault Platform via a new Openflow Connector. The connector enables organizations to access read-only Veeva data within Snowflake to run analytics and AI workflows across clinical, safety, regulatory, quality, and commercial operations without heavy engineering effort. This partnership advances agentic AI adoption in life sciences by bridging business process execution and enterprise data.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2021-12-13
Description

Veeva acquired Veracity Logic, a provider of cloud software for randomization and trial supply management (RTSM), to enhance its clinical offerings. The combined solutions support over 175 trials across 60 countries and serve multiple therapeutic areas in pharma, biotech, medical devices, and diagnostics.

Strategic tierMajorTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2021-08-03
Description

Veeva acquired Learnaboutgmp, a provider of GxP training content for the life sciences industry, to enhance its training solutions within its Vault Training platform. The acquisition aims to improve compliance and training outcomes for customers.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Veeva acquired Ostro in March 2026 for approximately $100 million. Ostro is a brand engagement platform for life sciences providing AI-driven chat experiences that allow patients and doctors to receive compliant, real-time answers from approved materials. Ostro operates as an independent unit within Veeva and will integrate with Veeva Commercial Cloud applications.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Veeva and BioMarin formed a long-term strategic partnership combining scientific capabilities with Veeva's technological leadership to bring transformative medicines more quickly to patients. BioMarin is expanding its use of Veeva's cloud platform across clinical, regulatory, and commercial operations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Roche expanded its strategic relationship with Veeva, committing to Vault CRM for personalized interactions that help teams better support healthcare professionals and patients. The partnership includes embedded AI capabilities for commercial execution.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Novo Nordisk International Operations committed to Veeva Vault CRM to empower global teams with next-generation CRM capabilities and agentic AI. The platform will help drive commercial execution for Novo Nordisk's global operations.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat7 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers20 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A9 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Veeva

Life Sciences Cloud Softwareveeva.com

Veeva Systems provides cloud-based software for the global life sciences industry, serving 1,500+ customers including 15 of the top 20 biopharma companies across clinical, regulatory, safety, quality, and commercial operations on its Veeva Vault Platform.

What Veeva does

Veeva Systems is a public cloud software company (NYSE: VEEV) founded in 2007 and headquartered in Pleasanton, California, that builds industry-specific applications for the global life sciences sector. The company operates the Veeva Vault Platform — a validated, regulated cloud infrastructure powering five product clouds: Veeva Development Cloud (clinical, eTMF, CTMS, RTSM, EDC, CDB, eCOA), Veeva Regulatory (RIM, Submissions), Veeva Safety Suite (pharmacovigilance), Veeva Quality Cloud (QMS, Training, LIMS, Batch Release, plus new EHS module), and Veeva Commercial Cloud (Vault CRM Suite, Ostro, Campaign Manager, Events Management, PromoMats, Align, Patient CRM). Supporting layers include the Veeva Data Cloud (OpenData, Link, Compass, Crossix) and a growing AI portfolio (Vault AI, Veeva Falcon, Veeva Falcon MLR). The company serves more than 1,500 customers across pharma, biotech, MedTech, consumer health, and CDMOs, including 15 of the top 20 global biopharma companies, with 4,000+ active Vault instances and 2M+ monthly active users.

Veeva's go-to-market is direct enterprise field sales targeting life sciences organizations through multi-year subscription contracts; the company maintains 5,001-10,000 employees and operates globally across North America, Europe, Asia Pacific, Latin America, and the Middle East. Revenue is overwhelmingly recurring — approximately 89% subscription, with subscription revenue of $730.2M in Q1 FY2027 (15% YoY) and total Q1 FY2027 revenue of $882.9M (16% YoY). Full-year FY2026 revenue was $3.195B and management has guided FY2027 to $3.635-3.645B. The Vault CRM Suite shows particularly strong momentum, with 140 customers live as of May 2026 (up from 125+ earlier in the year), 27 new customers added in Q1 FY2027, and an 80%+ competitive win rate.

The company pursues an aggressive AI- and acquisition-led growth strategy. Three acquisitions were completed in 2026 — Yonalink (clinical data, February), Ostro (AI brand engagement, ~$100M, March), and Copli (agentic MLR, rebranded as Veeva Falcon MLR, June) — alongside major product launches including Veeva Falcon (agentic platform, November 2026 early access) and Veeva EHS (August 2026). Veeva was added to the S&P 500 index on May 7, 2026, and the company operates as a Public Benefit Corporation under CEO and founder Peter Gassner. Strategic data ecosystem partnerships with Snowflake (Openflow Connector) and Databricks (Genie AI agents embedded in Vault CRM) extend the platform into customer data architectures, signaling a deliberate positioning as the workflow and AI orchestration layer for life sciences.

Veeva firmographics

Firmographics
Name
Veeva
Legal name
Veeva Systems Inc.
Website
https://veeva.com
Company type
Public
Founded year
2007
Operating status
Operating
Headcount range
51–100 employees
Short description
Veeva Systems provides cloud-based software for the global life sciences industry, serving 1,500+ customers including 15 of the top 20 biopharma companies across clinical, regulatory, safety, quality, and commercial operations on its Veeva Vault Platform.
Ownership category
akta.pro rank

Veeva industry classification

Industry
Product category
Life Sciences Cloud Software
NAICS
Software Publishers (513210)
SIC
Services-Prepackaged Software (7372)
akta.pro primary industry
Industry/Vertical Cloud Platforms (e.g., Gov/Healthcare/Financial Cloud Regions) (HDABAAAL)

Keywords

  • Life sciences cloud software
  • Clinical trial management
  • Regulatory information management
  • Pharmacovigilance safety systems
  • Pharmaceutical quality management

Where Veeva is headquartered

Location

Headquarters

HQ city
Pleasanton
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Veeva business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Subscription Revenue: Veeva generates the majority of its revenue (approximately 89% of total) from subscription-based software licenses for its Vault platform applications. Customers pay annual or multi-year subscription fees based on the number of users, applications deployed, and contract value. Subscription revenue grew 15% year-over-year to $730.2 million in Q1 FY2027.
  2. Professional Services: Implementation, consulting, and training services to help customers deploy and optimize Veeva applications. Professional services contributed $101.3 million in Q1 FY2026, representing approximately 11% of total revenue.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise Subscription Licensing

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Veeva product offering

Product offering

Core offering

Veeva Systems provides the industry cloud for life sciences, delivering cloud-based software on the Veeva Vault Platform for pharmaceutical, biotech, and MedTech organizations. The portfolio spans Veeva Development Cloud (clinical, regulatory, safety), Veeva Quality Cloud, Veeva Medical Suite, and Veeva Commercial Cloud (CRM and engagement), supported by data products and AI capabilities including Vault AI, Veeva Falcon, and Ostro. Approximately 89% of revenue comes from subscription fees, with the remainder from professional services.

Product overview

Veeva Systems provides a comprehensive industry cloud platform for life sciences, operating as a unified platform-plus-modules architecture. The portfolio spans five core clouds: Veeva Development Cloud (encompassing Veeva Clinical Platform, eTMF, CTMS, RTSM, EDC, CDB, eCOA), Veeva Regulatory (RIM, Registrations, Submissions), Veeva Safety Suite (Safety, SafetyDocs, Safety Signal, Safety Workbench), Veeva Quality Cloud (QualityDocs, QMS, Training, LIMS, Validation Management, Batch Release), and Veeva Commercial Cloud (Vault CRM Suite, Ostro, Campaign Manager, Events Management, Align, Patient CRM, PromoMats, Nitro). Supporting these are data products (OpenData, Veeva Link, Veeva Compass) and AI capabilities (Vault AI, Veeva Falcon, Veeva Falcon MLR). The platform serves pharma, biotech, MedTech, and other life sciences organizations across clinical, regulatory, quality, medical, and commercial operations.

Differentiator

Problem solved

Functional benefit

Brands

  • Veeva Vault: The company's cloud-based platform for life sciences applications
  • Veeva Development Cloud
  • Veeva Quality Cloud
  • Veeva Commercial Cloud
  • Veeva Safety Suite
  • Veeva RIM
  • Veeva Medical Suite
  • Ostro
  • Veeva Falcon
  • Veeva Falcon MLR
  • Veeva EHS
  • Veeva AI
  • Veeva Crossix
  • SiteVault
  • Veeva OpenData
  • Veeva Link
  • Veeva Compass
  • QualityOne

Products and services

  • Veeva Vault Platform
  • Veeva Development Cloud
  • Veeva Clinical Platform
  • Veeva eTMF
  • Veeva CTMS
  • Veeva RTSM
  • Veeva EDC
  • Veeva CDB
  • Veeva eCOA
  • Veeva RIM
  • Veeva Submissions
  • Veeva Safety Suite
  • Veeva Safety
  • Veeva Safety Signal
  • Veeva Quality Cloud
  • Veeva QualityDocs
  • Veeva QMS
  • Veeva Training
  • Veeva LIMS
  • Veeva Medical Suite
  • Veeva Vault CRM Suite
  • Ostro AI-powered brand engagement platform providing instant compliant answers for patients and HCPs using conversational AI and semantic search drawn from MLR-approved materials; trusted by 50% of the Top 20 global pharmaceutical companies.
  • Veeva Campaign Manager Marketing automation application for coordinating sales and marketing engagement in unified campaigns using both non-personal and field channels with segmented, multi-action campaigns.
  • Veeva Events Management
  • Veeva Align
  • Veeva Patient CRM
  • Veeva PromoMats
  • Veeva Nitro
  • Veeva OpenData
  • Veeva Link
  • Veeva Compass
  • Vault AI
  • Veeva Falcon Agentic platform with standard agents for life sciences drug development processes including trial master file document intake, health authority correspondence, and safety case triage; Veeva's first offering in 'agentic labor' for the industry.
  • Veeva Falcon MLR Agentic Medical, Legal, and Regulatory content-review platform that automates promotional and medical material reviews against approved labels and local regulations, aiming to eliminate over 70% of manual MLR work within five years.
  • Veeva EHS Environmental, Health, and Safety management application within Veeva Quality Cloud for proactive risk identification and mitigation while ensuring compliance with global requirements.
  • SiteVault

Quantifiable outcome

  • 50% faster time to market for promotional content
  • +9 more outcomes

Companies that use Veeva

Customer profile

Named customers20 records

Segments5 records

Ideal customer profiles3 records

Veeva technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability8 records

Feature9 records

Veeva partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and major.

  • CoplicoreOEM/ Whitelabel/ Licensing Partner · 23 June 2026Veeva acquired Copli, a Copenhagen-based pioneer in agentic medical, legal, and regulatory (MLR) solutions for the life sciences industry. Copli was rebranded as Veeva Falcon MLR, an agentic automation solution that automates promotional and medical material reviews against approved labels and local regulations.
  • ELIQUENT Life SciencescoreImplementation/ SI/ Consulting Partner · 1 June 2026ELIQUENT Life Sciences announced the June 1 go-live of Veeva Safety Suite at UCB, marking one of the first deployments of the complete suite globally. The transformation unified UCB's pharmacovigilance operations across case processing, signal management, and reporting into a single cloud-based platform. ELIQUENT led the implementation as the strategic collaboration partner.
  • Daelight SolutionsmajorImplementation/ SI/ Consulting Partner · 1 June 2026Daelight Solutions was part of the strategic collaboration delivering Veeva Safety Suite at UCB, migrating 14 million documents and 80 million records into the single cloud-based platform.
  • PinnaxismajorImplementation/ SI/ Consulting Partner · 1 June 2026Pinnaxis was part of the strategic collaboration delivering Veeva Safety Suite at UCB, providing implementation services for the pharmacovigilance transformation.
  • DatabrickscoreTechnology or Integration · 18 May 2026Databricks and Veeva integrated their platforms to enable life sciences commercial teams to access real-time AI-powered insights directly within Veeva Vault CRM workflows. The integration embeds Databricks Genie AI agents and AI/BI dashboards into the CRM, allowing field teams to query patient signals, HCP prioritization data, KOL information, and territory analytics on demand.
  • Accumulus TechnologiescoreTechnology or Integration · 7 May 2026Accumulus Technologies announced live integration with Veeva RIM, creating real-time connection between Veeva's regulatory information management system and the Accumulus platform for global health authority collaboration. The integration enables life sciences companies to manage regulatory interactions directly within their existing Veeva RIM environment, eliminating manual reconciliation and system switching. Amgen is among the first companies to deploy the solution.
  • SnowflakecoreTechnology or Integration · 6 May 2026Snowflake and Veeva announced a collaboration to connect Snowflake's AI Data Cloud for Healthcare & Life Sciences with the Veeva Vault Platform via a new Openflow Connector. The connector enables organizations to access read-only Veeva data within Snowflake to run analytics and AI workflows across clinical, safety, regulatory, quality, and commercial operations without heavy engineering effort. This partnership advances agentic AI adoption in life sciences by bridging business process execution and enterprise data.
  • Veracity LogiccoreOEM/ Whitelabel/ Licensing Partner · 13 December 2021Veeva acquired Veracity Logic, a provider of cloud software for randomization and trial supply management (RTSM), to enhance its clinical offerings. The combined solutions support over 175 trials across 60 countries and serve multiple therapeutic areas in pharma, biotech, medical devices, and diagnostics.
  • LearnaboutgmpmajorOEM/ Whitelabel/ Licensing Partner · 3 August 2021Veeva acquired Learnaboutgmp, a provider of GxP training content for the life sciences industry, to enhance its training solutions within its Vault Training platform. The acquisition aims to improve compliance and training outcomes for customers.
  • OstrocoreOEM/ Whitelabel/ Licensing PartnerVeeva acquired Ostro in March 2026 for approximately $100 million. Ostro is a brand engagement platform for life sciences providing AI-driven chat experiences that allow patients and doctors to receive compliant, real-time answers from approved materials. Ostro operates as an independent unit within Veeva and will integrate with Veeva Commercial Cloud applications.
  • BioMarincoreStrategic or Co-development PartnerVeeva and BioMarin formed a long-term strategic partnership combining scientific capabilities with Veeva's technological leadership to bring transformative medicines more quickly to patients. BioMarin is expanding its use of Veeva's cloud platform across clinical, regulatory, and commercial operations.
  • RochecoreStrategic or Co-development PartnerRoche expanded its strategic relationship with Veeva, committing to Vault CRM for personalized interactions that help teams better support healthcare professionals and patients. The partnership includes embedded AI capabilities for commercial execution.
  • Novo NordiskcoreStrategic or Co-development PartnerNovo Nordisk International Operations committed to Veeva Vault CRM to empower global teams with next-generation CRM capabilities and agentic AI. The platform will help drive commercial execution for Novo Nordisk's global operations.

Scale indicators23 records

Recent moves7 records

Expansion highlights6 records

Veeva competitors and assessment

Company assessment

Market position

Competitive moat7 records

Key highlights7 records

Customer concentration

Veeva social profiles

Digital presence

Veeva compliance and trust

Trust signal

Compliance4 records

Veeva financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Veeva leadership team

Management profile

Number of profiles

Profiles12 records

Veeva subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Veeva funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Veeva M&A and investment

M&A and investment

M&A9 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Veeva

What does Veeva do?

Veeva Systems provides the industry cloud for life sciences, delivering cloud-based software on the Veeva Vault Platform for pharmaceutical, biotech, and MedTech organizations. The portfolio spans Veeva Development Cloud (clinical, regulatory, safety), Veeva Quality Cloud, Veeva Medical Suite, and Veeva Commercial Cloud (CRM and engagement), supported by data products and AI capabilities including Vault AI, Veeva Falcon, and Ostro. Approximately 89% of revenue comes from subscription fees, with the remainder from professional services.

Is Veeva a public or private company?

Veeva is a public company. It is classified as public and is currently operating.

When was Veeva founded?

Veeva was founded in 2007. It employs 51 to 100 people.

Where is Veeva based?

Veeva is headquartered in Pleasanton, United States, in the North America region.

How does Veeva make money?

Two revenue lines are on record. Subscription Revenue is the primary driver. The others are professional Services.

Does Veeva have an API?

Yes. Veeva offers an Openflow Connector that enables organizations to access read-only Veeva data within Snowflake for end-to-end analytics and AI workflows across clinical, safety, regulatory, quality, and commercial operations. The Snowflake Openflow Connector allows import of Veeva data into Snowflake for analytics and AI purposes while maintaining data integrity and compliance within Veeva's validated system. Developer documentation is at www.veeva.com/products/vault-platform.

What industry is Veeva in?

Veeva's product category is Life Sciences Cloud Software. Its primary akta.pro industry code is HDABAAAL, Industry/Vertical Cloud Platforms (e.g., Gov/Healthcare/Financial Cloud Regions). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MarketScreenerVeeva Systems Announces More Than 175 Emerging Biotechs Standardize On Veeva Basics To Accelerate Drug DevelopmentVeeva Systems announced that over 175 emerging biotechs are adopting Veeva Basics to build a technology foundation. The platform provides pre-configured, pre-validated applications for clinical, regulatory, quality, medical, and commercial functions, enabling faster scaling from startup to commercialization. It also supports insourcing regulatory publishing, such as FDA submissions.YahooVeeva's DQS Scales Data Automation Across 1,000+ Clinical StudiesVeeva Systems said its DQS platform has supported data cleaning across more than 1,000 clinical studies involving over 1 million subjects. The system generated over 500,000 automated queries, and shares traded flat after the announcement. Veeva's market cap is $45.89 billion.PR NewswireLes entreprises biotechnologiques émergentes adoptent Veeva Basics pour accélérer le développement de médicamentsVeeva Systems announced that over 175 emerging biotech companies are deploying preconfigured Veeva Basics applications to accelerate drug development. The platform covers clinical, regulatory, quality, medical, and commercial domains, and companies are internalizing regulatory submissions. Veeva also promoted its upcoming R&D and Quality Summit in Boston.Investing.comVeeva Systems reports over 175 biotechs using Basics platformVeeva Systems announced that over 175 emerging biotechnology companies have adopted its Veeva Basics platform. The pre-configured applications help biotechs establish clinical, regulatory, quality, medical, and commercial operations, with implementations in weeks. Veeva will host its R&D and Quality Summit in Boston on October 20-21.PRESSBEEEmerging Biotechs Standardize on Veeva Basics to Accelerate Drug Development ...Middle EastVeeva Systems announced that more than 175 emerging biotechs are establishing a technology foundation with Veeva Basics. The pre-configured applications are intended to streamline operations and accelerate drug development.Stock TitanVeeva Systems Basics adoption tops 175 biotechsVeeva Systems announced that more than 175 emerging biotechs are using Veeva Basics to establish a technology foundation. The pre-configured applications enable biotechs to scale from startup to commercialization, with applications for clinical, regulatory, quality, medical, and commercial operations. The company also promoted its R&D and Quality Summit in Boston.American Banking and Market NewsCritical Comparison: Veeva Systems (NYSE:VEEV) and DarioHealth (NASDAQ:DRIO)Veeva Systems and DarioHealth are compared across risk, profitability, ownership, analyst ratings, and valuation. Veeva beats DarioHealth on 12 of 14 factors, with higher revenue and earnings, but DarioHealth shows higher upside potential. The comparison highlights Veeva's stronger institutional ownership and profitability.PR NewswireEmerging Biotechs Standardize on Veeva Basics to Accelerate Drug DevelopmentVeeva Systems announced that more than 175 emerging biotechs are using its Veeva Basics platform to streamline operations. The pre-configured applications enable biotechs to scale from startup to commercialization, with customers citing faster regulatory timelines and improved quality control.PR NewswireLas empresas biotecnológicas emergentes estandarizan sus procesos con Veeva BasicsVeeva Systems announced that over 175 emerging biotech companies are standardizing their processes with Veeva Basics, using preconfigured applications to accelerate drug development. The platform unifies clinical, regulatory, quality, medical, and commercial operations, enabling faster scaling from early stages to commercialization. Veeva also promotes an upcoming research and quality summit in Boston.PR NewswireEmerging Biotechs Standardize on Veeva Basics to Accelerate Drug DevelopmentVeeva Systems announced that more than 175 emerging biotechs are using its Veeva Basics platform to streamline operations. The pre-configured applications enable biotechs to scale from startup to commercialization, with customers citing faster regulatory timelines and improved quality control. The company also promoted an upcoming R&D and Quality Summit in Boston.